<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Infect Dis Obstet Gynecol</journal-id><journal-title>Infectious Diseases in Obstetrics and Gynecology</journal-title><issn pub-type="ppub">1064-7449</issn><issn pub-type="epub">1098-0997</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18475377</article-id><article-id pub-id-type="pmc">2364371</article-id>
        <article-id pub-id-type="pii">S1064744994000505</article-id>
        <article-id pub-id-type="doi">10.1155/S1064744994000505</article-id>
    <article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Comparison of Short Vs. Long Half-Life Single-Dose Prophylactic Antibiotics for Cesarean Section</article-title></title-group><contrib-group>
            <contrib contrib-type="author" corresp="yes"><name><surname>Gonik</surname><given-names>Bernard</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref></contrib>
             <contrib contrib-type="author"><name><surname>McGregor</surname><given-names>James</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib>
       </contrib-group>
            <aff id="aff1"><label>1</label>
                <addr-line>Department of Obstetrics and Gynecology</addr-line>
                <addr-line>University of Texas Medical School at Houston</addr-line>
                <addr-line>Houston</addr-line>
                <addr-line>TX</addr-line>
                <country>USA</country>
            </aff>
            <aff id="aff2"><label>2</label>
                <addr-line>Department of Obstetrics and Gynecology</addr-line>
                <addr-line>University of Colorado Health Sciences Center</addr-line>
                <addr-line>Denver</addr-line>
                <addr-line>CO</addr-line>
                <country>USA</country>
            </aff>
            <aff id="aff3"><label>3</label>
                <addr-line>Department of Obstetrics and Gynecology</addr-line>
                <addr-line>Wayne State University School of Medicine</addr-line>
                <addr-line>Grace Hospital</addr-line>
                <addr-line>6071 W. Outer Drive</addr-line>
                <addr-line>Detroit</addr-line>
                <addr-line>MI</addr-line>
                <addr-line>48235</addr-line>
                <country>USA</country>
            </aff>
            <pub-date pub-type="ppub"><year>1994</year></pub-date><volume>2</volume><issue>3</issue><fpage>120</fpage><lpage>125</lpage><history><date date-type="received"><day>12</day><month>4</month><year>1994</year></date><date date-type="accepted"><day>6</day><month>7</month><year>1994</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 1994 Hindawi Publishing Corporation.</copyright-statement><copyright-year>1994</copyright-year><copyright-holder>Hindawi Publishing Corporation</copyright-holder><license license-type="open-access" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract>
<p><italic>Objective:</italic> Numerous studies demonstrate the efficacy of antibiotic prophylaxis for reducing postcesarean
section infectious morbidity. The duration of therapy, however, remains controversial.
Cost containment measures and the ease of single dosing have led to the introduction of &#x0201c;extended&#x0201d;
half-life agents for cesarean-section chemoprophylaxis. We tested the hypothesis that there was no
difference in efficacy between a single dose of a short half-life agent (cefoxitin) and a longer half-life
agent (cefotetan).</p>
<p><italic>Methods:</italic> A prospective, double-blind trial of 375 non-elective cesarean-section cases was carried
out. Study antibiotics (2 g) were administered intravenously (IV) at cord clamping only.</p>
<p><italic>Results:</italic> Demographic and clinical variables between the 2 study groups were similar. No significant
differences were noted in major or minor morbidity or in infectious morbidities for patients
receiving the 2 prophylactic regimens. The occurrence of postoperative endometritis was likewise
similar for the subjects receiving cefoxitin (10%) and cefotetan (15%). When cases whose surgery
lasted &#x0003e;60 min were evaluated separately, no differences in outcomes between the 2 groups were
identified</p>
<p><italic>Conclusions:</italic> These findings confirm our hypothesis that the half-life difference between these 2
agents does not impact on single-dose Prophylactic efficacy in cesarean section.</p>
</abstract></article-meta></front></article>


